SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001640334-20-003129
Filing Date
2020-12-22
Accepted
2020-12-22 16:40:47
Documents
2
Period of Report
2020-12-22
Effectiveness Date
2020-12-22

Document Format Files

Seq Description Document Type Size
1 DEF 14A embi_def14a.htm DEF 14A 548722
2 embi_def14aimg2.jpg GRAPHIC 4409
  Complete submission text file 0001640334-20-003129.txt   556281
Mailing Address 5910 PACIFIC CENTER BLVD, SUITE 320 SAN DIEGO CA 92121
Business Address 5910 PACIFIC CENTER BLVD, SUITE 320 SAN DIEGO CA 92121 (949) 480-9051
Emerald Bioscience, Inc. (Filer) CIK: 0001516551 (see all company filings)

IRS No.: 450692882 | State of Incorp.: NV | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 000-55136 | Film No.: 201408491
SIC: 2834 Pharmaceutical Preparations